Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IPOs
IPOs
Will This 2020 Biotech IPO Crush the Market This Year?
Motley Fool
Tue, 06/29/21 - 10:57 am
Legend Biotech
IPOs
Multiple Myeloma
With sickle cell disease study in sight, Graphite Bio draws up a $238M IPO
MedCity News
Sun, 06/27/21 - 10:47 pm
Graphite Bio
IPOs
sickle cell disease
Elevation Oncology
Monte Rosa
Another four IPOs complete busy week as biotech raise continues to match 2020's record pace
Endpoints
Fri, 06/18/21 - 10:06 am
IPOs
Lyell Immunopharma
Verve Therapeutics
Molecular Partners
ATAI Life Sciences
Century Therapeutics
Ambrx
Cyteir Therapeutics
Bloom is off the health tech IPO rose, as valuations expected to fall
MedCity News
Thu, 06/17/21 - 12:16 pm
IPOs
devices
digital health
healthtech
Medtech
Molecular Partners prices $64M IPO, falling short of original goal
Fierce Biotech
Wed, 06/16/21 - 11:49 am
Molecular Partners
IPOs
Versant-backed Bright Peak sets a date to bring its IL-2 into the clinic — but all eyes are on an IPO after latest mega-round drops
Endpoints
Thu, 06/10/21 - 11:08 am
Bright Peak Therapeutics
Versant
IPOs
funding
cytokines
Acumen rides aducanumab, amyloid and Alzheimer's waves on its IPO voyage
Fierce Biotech
Thu, 06/10/21 - 11:04 am
Acumen
IPOs
Aduhelm
Biogen
Elevation files for $100M IPO to fund tumor-agnostic candidate
Fierce Biotech
Mon, 06/7/21 - 11:11 am
Elevation Oncology
IPOs
Merrimack Pharmaceuticals
solid tumors
Gene editing biotech Verve indicates a swift swerve onto Wall Street, asking for $100M IPO
Fierce Biotech
Tue, 06/1/21 - 10:50 pm
Verve Therapeutics
IPOs
gene editing
heart disease
Centessa Pharma’s IPO brings in $330M for its new model of drug R&D
MedCity News
Tue, 06/1/21 - 10:59 am
IPOs
Centessa Pharmaceuticals
R&D
This Recent Healthcare IPO Posted Solid Earnings, but Wall Street Wasn't Listening
Motley Fool
Mon, 05/31/21 - 06:57 pm
Eargo
hearing aids
devices
IPOs
earnings
Centessa raises $330M in third largest biotech IPO this year
BioPharma Dive
Fri, 05/28/21 - 11:19 am
Centessa Pharmaceuticals
IPOs
GSK-backed Lyell Immunopharma, fresh off a near $500M cash injection, guns for a $150M IPO
Fierce Biotech
Wed, 05/26/21 - 11:16 am
Lyell Immunopharma
GSK
IPOs
funding
solid tumors
Landos Biopharma teams up with LianBio for $218M-plus collab and sales deal for 2 immunology assets in Asia
Fierce Biotech
Mon, 05/17/21 - 10:44 am
LianBio
Landos Biopharma
IPOs
ulcerative colitis
Crohn's Disease
China
Asia
Talaris pulls off $150M IPO to tackle organ rejection, autoimmune disorders
Fierce Biotech
Fri, 05/7/21 - 10:50 am
IPOs
Talaris Therapeutics
organ rejection
Hours before expected debut, Gyroscope postpones its IPO as 2 other biotechs hold the line on their march to Nasdaq
Endpoints
Fri, 05/7/21 - 10:33 am
IPOs
Gyroscope Therapeutics
Two Biotechs Gear Up for Nasdaq Debut
BioSpace
Tue, 05/4/21 - 10:47 pm
Gyroscope Therapeutics
Talaris Therapeutics
IPOs
NASDAQ
Biotech IPO wave rolls on as Werewolf, Vaccitech raise $230M for clinical trials
MedCity News
Sun, 05/2/21 - 10:16 pm
Werewolf Therapeutics
Vaccitech
IPOs
cancer immunotherapy
vaccines
This Is Why Zymergen's IPO Was a Huge Success
Motley Fool
Tue, 04/27/21 - 11:31 pm
Zymergen
IPOs
synthetic biology
Molecular Partners Files $100 Million IPO to Advance COVID-19 and Cancers Therapies
BioSpace
Sun, 04/25/21 - 01:47 pm
Molecular Partners
IPOs
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »